This study wants to find out whether medications currently prescribed to treat people with diabetes and heart problems could be used to prevent heart problems.

It is being carried out by a team of researchers at the University of Vienna, with the University of Glasgow and NHS Greater Glasgow and Clyde acting on their behalf in the UK.

Investigating whether treating iron deficiency with injections can prevent people with heart failure from being admitted to hospital and improve their overall outcomes.

Further reading

• Kalra, P.R., Cleland, J.G.F., Petrie, M.C., Thomson, E.A., Kalra, P.A., Squire, I.B., Ahmed, F.Z., Al-Mohammad, A., Cowburn, P.J., Foley, P.W.X., Graham, F.J., Japp, A.G., Lane, R.E., Lang, N.N., Ludman, A.J., Macdougall, I.C., Pellicori, P., Ray, R., Robertson, M. and Seed, A. (2022). Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. The Lancet. doi:10.1016/s0140-6736(22)02083-9.

‌